Alexion to Pay More Than $21 Million to Settle SEC Charges

·

·

Alexion to Pay More Than $21 Million to Settle SEC Charges

Alexion Pharmaceuticals Inc. is expected to pay more than $21 million to settle charges of violations of the Foreign Corrupt Practices Act, according to the Securities and Exchange Commission. Two of Alexion’s subsidiaries—Alexion Turkey and Alexion …
See Original Article

TSA Shares Travel Tips Ahead of 2020 Fourth of July Holiday Weekend

Air travel has changed over the last few months, hitting record lows, but this hasn’t stopped crowds at the airport or unruly passengers on planes. TSA is trying to curtail the number of naughty passengers who are traveling this holiday weekend by sharing tips …
See Original Article

US Treasury agrees on loan terms with American, four other airlines

WASHINGTON (Reuters) – The U.S. Treasury said on Thursday it has agreed on terms for government loans with five U.S. carriers, including American Airlines Group Inc (AAL.O). FILE PHOTO: An American Airlines Boeing 737 jet sits at a gate at Washington’s …
See Original Article

High-flying IPOs for Lemonade and Accolade may encourage other unicorns to go public

If you’d predicted in late March and early April that Q3 would kick off with a wide-open IPO market and receptive investors, I doubt anyone would have believed you. If you suggested that valuations would look pretty good as well, you might even have been …
See Original Article

Amgen's Enbrel fends off biosimilar threat—and heads toward blockbuster superstardom

With Amgen’s top line facing pressure for quite some time from biosimilar versions of flagship drugs like Epogen and Neulasta, the prospect that it could lose exclusivity on its top-selling product, anti-inflammatory Enbrel, has been a nagging worry. So it was …
See Original Article



Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.